Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00607503 · ClinicalTrials.gov registry record · Phase 1
A Pilot Study to Evaluate the Safety of Terbutaline in Children With Type 1 Diabetes
A Phase 1 study, sponsored by Jaeb Center for Health Research.
- Completed
- Registry status
- Phase 1
- Development phase
- 9
- Enrollment target
NCT00607503 is a Phase 1 study that has completed, run by Jaeb Center for Health Research. The registered enrollment target is 9 participants.
The verdict
NCT00607503, a Phase 1 study, has completed, sponsored by Jaeb Center for Health Research.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 9 participants
- Enrollment target
Study Summary
The purpose of the study is to gain experience with the use of terbutaline in children with T1D and to determine that there is not a frequent serious, unexpected, uncontrollable effect on short-term glycemic control. Some information also will be obtained with regard to whether terbutaline, in the dosing being used in the study, is sufficiently well tolerated to expect that adherence will be satisfactory in a large randomized trial. In addition, this pilot study will provide data on the accuracy of a continuous glucose monitor during terbutaline use to verify that the drug does not impact on sensor function.
Interventions
- DRUG Terbutaline
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 9 participants |
| Start Date | 2008-02 |
| Est. Completion | 2008-09 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00607503
The ClinicalTrials.gov registry entry for NCT00607503 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 9 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Jaeb Center for Health Research, which has 119 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Terbutaline is the first listed.
NCT00607503 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00607503 about?
NCT00607503 is a clinical study titled "A Pilot Study to Evaluate the Safety of Terbutaline in Children With Type 1 Diabetes". The purpose of the study is to gain experience with the use of terbutaline in children with T1D and to determine that there is not a frequent serious, unexpected, uncontrollable effect on short-term glycemic control. Some information also will be obtained with regard to whether terbutaline, in the d...
What is the current status of trial NCT00607503?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 9 participants. The study started on 2008-02. Estimated completion is 2008-09.
What interventions are being tested in trial NCT00607503?
The interventions under investigation include: Terbutaline (DRUG).
Who is sponsoring clinical trial NCT00607503?
This trial is sponsored by Jaeb Center for Health Research, which has 119 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.